Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

DipHIV > Neuro OI > Flashcards

Neuro OI Flashcards

1
Q

Differentials for SOL on imaging

A

Toxoplasmosis, primary CNS lymphoma, TB, cryptococcus, non-Hodgkin lymphoma, syphillitis gummae

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Possible causes of encephalitis

A

HIV, VZV, HSV, syphilis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Causes of meningitis

A

HIV seroconversion, cryptococcus, TB, syphilis, bacterial (eg strep pneumoniae)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Different causes of spastic paraparesis

A

HIV-vacuolar myelopathy, transverse myelitis from VZV, HSV, HTLV-1, toxoplasmosis, syphilis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Causes of polyradiculitis

A

CMV, NHL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What organism is most commonly associated with HIV related cryptococcal disease in the UK?

A

Cryptococcus neoformans var grubii (serotype A)

2nd most is cryptococcus neoformans bar neoformans (serotype D)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Where is c. neoformans var neoformans found?

A

Bird (primarily pigeon) droppings
(Non avian sources are also found)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Where is c. Neoformans var gatii found?

A

Eucalyptus trees
Therefore infections mainly in tropical and subtropical regions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What does cryptococcal skin disease look like?

A

Molluscum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Pathway of cryptococcus through the body

A

Inhaled into lungs.
May then cause localised disease.
Spreads to blood and diseminates.
Prostate can be a sanctuary site.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Symptoms of cryptococcal meningitis

A

Headache, fever
Meningism variable
Raised ICP may cause nausea, vomitting, confusion, coma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What might you see on CXR in pulmonary cryptococcal disease

A

Variable but include -
Widespread infiltration, nodular disease, isolated abscess formation, pleural effision

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Rarer presentations of cryptococcal disease

A

Ocular palsy, papilloedema, chorioretinitis, osteolytic bone lesions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How to diagnose cryptococcal disease

A

Serum CrAg - generally if negative this excludes disseminated disease
If CrAg positive needs LP with manometry (after CT/MRI)
Fungal culture

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Possible causes of false positive serum CrAg

A

Rheumatoid factor, heterophile antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What should CSF be sent for if suspecting cryptococcal disease?

A

CrAg
Microscopy - India ink stain
Culture

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What would you expect to see on India ink stain?

A

Clear around the wall of the yeast as the carbon grains cannot penetrate the capsule
(Cryptococcus)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What role do fungal sensitivities play in tx of cryptococcal disease?

A

ONLY if not responding to treatment can be used to guide a switch

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Factors indicating poor prognosis in cryptococcal disease

A

Blood culture positive
Low white cells in CSF
High CSF CrAg
Confusion
Raised ICP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is the induction treatment for neuro cryptococcal disease?

A

Liposomal Amphotericin B (ambisome) 4mg/kg/day IV (preferred)
Plus flucytosine 100mg/kg/day

Historically amphotericin B deoxycholate 0.7-1mg/kg/day used

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Role of flucytosine in cryptococcal meningitis treatment

A

Speeds rate of sterilisation of CSF
Reduces incidence of relapse in patients not on HAART

Associated with enhanced toxicity in some studies, no impact on mortality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Why do we use ambisome rather than standard amphotericin B?

A

At least equivalent efficacy
Less nephrotoxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What would be an alternative therapy for cryptococcal meningitis if ambisome not tolerated?

A

Fluconazole 400mg/day +/- flucytosine

May be used as first line if good prognostic factors as easier to administer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Treatment of refractory cryptococcal meningitis

A

If all normal meds not tolerated can try newer Azoles voriconazole and posaconazole - expensive.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Management of raised ICP in cryptococcal meningitis

A

If opening pressure >25 reduce to below 20 or to 50% initial pressure
Repeat daily until stable
If resistant may require shunt

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What is the maintenance therapy for cryptococcal meningitis?

A

Oral fluconazole 400mg OD 10/52 started after 2 weeks if patient is well

After 10 weeks drop to 200mg OD

Alternative weekly ambisome (fluconazole superior and less toxicity)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

When would you not want to switch to maintenance therapy for cryptococcal meningitis at 2 weeks?

A

If poor prognostic factors and poor response to treatment repeat LP and consider prolonging induction therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

How does LP impact options of tx for cryptococcal meningitis??

A

Historically would wait until CSF sterile to move to maintenance therapy
Not all doctors do this - if HAART is going to be started after 2 weeks risk of relapse and mortality likely to be less than seen in older studies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Treatment for isolated pulmonary cryptococcal disease

A

LP TO CHECK FOR OCCULT CNS DISEASE
If this is negative - treat pulmonary disease with fluconazole if moderate symptoms
If severe treat with ambisome until symptoms are controlled
Follow with prophylaxis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Do we give primary prophylaxis for cryptococcal disease?

A

No.
No effect on survival, risk of resistance, high cost

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

When to start ARVs in cryptococcal meningitis?

A

After 2 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Why is ARV delayed for 2 weeks if being treated for cryptococcal meningitis?

A

Risk of IRIS

33
Q

When can secondary prophylaxis for cryptococcal meningitis be stopped?

A

Once CD4 >100 in presence of undetectable VL for at least 3 months

34
Q

What is the most common cause of mass lesions in immunocompromised HIV+ individuals?

A

Toxoplasma abscesses

35
Q

How is toxoplasma infection acquired?

A

From cats
Either eating animals with disseminated infection or injection of oocytes from cat faeces contaminating soil, fruit, veg, water.

36
Q

What is the lifetime risk of an untreated HIV+ person with toxo IgG positive developing toxoplasma encephalitis?

A

25%

37
Q

Is toxoplasma infection in immunodeficiency patient usually due to primary infection or reactivation?

A

Reactivation

38
Q

What is the clinical presentation of toxoplasmosis cerebral abscess?

A

Develops over days to weeks
Focal neurological signs, symptoms, sometimes seizures
If raised ICP - headaches and vomitting
Hemiparesis, visual field deficits, dysphasia, cerebellar syndrome and movement disorders - abscesses have predilection for basal ganglia

39
Q

How might toxoplasmosis present outside the nervous system?

A

Chorioretinitis
Pneumonia

40
Q

Differential diagnosis of toxoplasma abscesses

A

PCNSL, tuberculous abscesses, PML

41
Q

What imaging would you request for ?toxoplasma abscesses?

A

MRI preferable to CT
SPECT may be helpful to exclude PCNSL

42
Q

What are typical MRI findings with toxoplasmosis?

A

Multiple ring enhancing lesions at grey-white matter interface and in deep grey matter of basal ganglia or thalamus with cerebral oedema and mass effect

43
Q

How might a low CD4 count impact MRI appearance of toxoplasma abscesses?

A

Absence of ring enhancement

44
Q

Should you do an LP if you suspect toxoplasma abscesses?

A

May be helpful if diagnostic uncertainty but often contraindicated due to raised ICP.
CSF toxo PCR sensitivity 50% specificity >94%

45
Q

When should a brain biopsy be performed in someone being treated for toxoplasmosis?

A

Lack of response after 2 weeks of treatment, clinical deterioration or atypical features

46
Q

What is the sensitivity and specificity of PCR for toxo on CSF?

A

Sensitivity 50%
Specificity >94%

47
Q

What is the first line treatment of toxoplasma encephalitis?

A

Loading dose 200mg pyrimethimine followed by 50mg/day (<60kg) to 75mg/day (>60kg)
Plus folinic acid 15mg/day
Plus either sulphadiazine 1-2g QDS or 15mg/kg QDS or clindamycin 600mg qds

For 6 weeks

48
Q

Why is folinic acid given in treatment of toxo encephalitis?

A

Counteracts myelosupressive effect of pyrimethamine

49
Q

What route should sulphadiazine be given in tx of toxo encephalitis?

A

Not available IV in UK.
Good oral bioavailability so give orally or via NG if unconscious.
If IV a necessity use clindamycin instead.

50
Q

What is the likely cause of a rash while on treatment for toxoplasma encephalitis?

A

Generalised maculopapular rash most likely to be caused by sulphadiazine or clindamycin component.
Stop and switch to the other is possible.
Sulpha desensitisation possible but slow.

51
Q

In the treatment of toxoplasma encephalitis why is sulphadiazine preferred over clindamycin?

A

Study showing less response to clindamycin in acute phase and two fold risk of progression in maintenance phase in clindamycin group

52
Q

What is the maintenance therapy for toxoplasma encephalitis?

A

Same drugs lower doses
Pyremethimine 25mg/day
Sulphadiazine 500mg qds or 1-2g BD
Folinic acid 15mg/day

53
Q

How should you treat toxoplasma encephalitis if recommended regime not tolerated?

A

P and FA plus atovaquone 1500mgBD

Sulphadiazine plus atovaquone 1500mg bd

P and FA plus either azithro/Clari/doxy/dapsone AND trimethoprim and sulphamethoxazole

54
Q

Who should have primary prophylaxis for toxoplasma encephalitis?

A

Hiv patients with CD4 < 200 and positive toxoplasma serology

55
Q

What is the primary prophylaxis for toxoplasma encephalitis?

A

Septrin 480-960mg/day

Dapsone 50mg/day and pyrimethamine 50mg/week reserved for those allergic to septrin

56
Q

When should you start ARVs in patient being treated for toxoplasma encephalitis?

A

As soon as clinically stable - approx 2 weeks - to lessen likelihood of IRIS

57
Q

When can primary prophylaxis for toxoplasma encephalitis be stopped?

A

VL suppressed and CD4 >200 for 3/12

58
Q

When should toxoplasma encephalitis maintainable therapy be stopped?

A

After 6 months of successful VL suppression and cd4 >200

59
Q

How does the JC virus affect people?

A

JC virus
Asymptomatic seroconversion in childhood
Disseminates and sets up reservoirs in spleen, kidneys, bone marrow, b lymphocytes
Replicates in immunosuppression and b lymphocytes transport to brain and infect oligodendrocytes via serotonin receptor

60
Q

Classic symptoms of PML

A

Subacute illness without constitutional symptoms

Focal neurology
Mainly motor deficit
Altered mental/mood status
Ataxia
Cortical visual symptoms
Over weeks to months

61
Q

How can PML be distinguished from HIV encephalopathy?

A

Presence of focal neurology

62
Q

What are typical MRI findings for PML?

A

Lesions - Bilateral, asymmetric, non enhancing t2 hyperintense t1 hypointense, restricted to white matter, no oedema

63
Q

How to diagnose PML?

A

MRI
CSF for JC virus
Sufficient in most cases so avoid need for brain biopsy (gold standard)

64
Q

What is affect of ART on CSF JC DNA testing?

A

Reduced viral replication and increased clearance - reduces sensitivity of test to 50% from 72-90%

65
Q

What are poor prognostic factors in PML?

A

Clinical - older age, brainstem involved, decreased GCS
Viral - high CSF JC VL with delayed clearance
Radiological - early brainstem involvement
Immunological - cd4<100

66
Q

Improved prognostic factors in PML?

A

Higher CD4 counts, contrast enhancement on in imagine, perivascular mononuclear infiltrated, JC specific cytotoxic t lymphocytes

67
Q

Treatment for PML

A

ARVs only therapeutic option
One study showed better outcome with drugs based on higher CNS penetration score

68
Q

Prognosis in PML

A

50% survival at one year if on ARVs
Some enter true remission of disease

69
Q

Symptoms of CMV nervous system disease

A

Progressive disorientation, withdrawl, apathy, cranial nerve palsies

Insensitive and difficult to distinguish from aids dementia complex

Depression and mental slowing more evident in aids dementia complex

70
Q

How does CMV lumbosacral polyradiculitis present?

A

Rapidly progressive, painful, bilateral ascending flaccid paralysis with saddle anaesthesia, areflexia, sphincter dysfunction

71
Q

What percentage of those with CMV nervous system involvement have cerebellar or brainstem involvement?

A

30%

72
Q

Diagnosis of neuro CMV

A

MRI and CSF CMV PCR

73
Q

Radiological findings if CMV

A

Ct - diffuse white matter hypodensities with effacement, ventricular enlargement, meningeal enhancement, focal or nodular ring enhancing lesions

MRI far more sensitive for these features on GAD enhanced scan

Imaging lacks sensitivity

74
Q

Treatment for neurological CMV disease?

A

No prospective controlled trials for this

Gancyclovir plus/minus foscarnet
ARVs critical

75
Q

Prophylaxis against CMV encephalitis/polyradiculitis

A

Not required but ARVs likely to to decrease incidence of conditions

76
Q

When can maintainence therapy for CMV encephalitis/polyradiculitis be stopped?

A

For reitinitis stop when sustained cd4>100 - evidence not there to do that in neuro cmv. Cautious approach based on clinical, CSF and blood cmv dna levels, imaging improvement

77
Q

Treatment of cryptococcal infection during pregnancy?

A

Ambisome as per non pregnant

However flucytosine teratogenic so should be avoided in first trimester wherever possible and only used in rest of
Pregnancy if benefits outweigh risks

High Fluconazole doses should be avoided and switched for ambisome in early pregnancy - can be used in later stages of pregnancy as secondary prophylaxis

78
Q

Treatment of toxoplasma in pregnancy?

A

Sulphadiazine and pyrimethamine - should be given with folinic acid

No clear evidence of teratogenicity in humans

If sulphadiazine is continues in 3rd trimester can cause neonatal haemolysis and methaemaglobinaemia

79
Q

How is CMV treated in pregnancy?

A

Systemic therapy for systemic disease - all available agents associated with congenital anomalies in rats and rabbits - iv ganciclovir used most and considered first line

If foscarnet used due to potential for renal toxicity amniotic fluid needs monitoring for oligohydramnios

Isolated CMV retinitis should be treated with local Intravitreal therapy or implants

DipHIV (19 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions